The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...

My dad was always going to go down swinging. This was a man who’d spent the first year of his life in a neonatal intensive ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

Peer-reviewed research from the Clayman Thyroid Center at the Hospital for Endocrine Surgery highlights a major gap in ...

Men with prostate cancer have a major decision to make: whether to get a lifesaving surgery. Radical prostatectomy, the ...

The belief that surgery spreads cancer is a common public misconception. Onco-surgeon Yogeshwar Shukla spoke to Free Press on ...

The former president spoke at a St. Patrick's Day breakfast in Boston.

EDAP management highlighted what it sees as a growing global opportunity for therapeutic ultrasound in urology, emphasizing ...

Primary endpoint analysis at 1 year showed better maintenance of erectile function and pad-free continence with TULSA than with robotic radical prostatectomy. Peri-procedural metrics favored TULSA, ...

Cancer surgery often requires patients to travel to the specialist. This time, the specialist traveled to the patient. Doctors at The London Clinic remotely guided a robotic system to remove a man's ...